Brevetti EPO No.2925324 2020.12.30
Brevetti EPO
(10) Registration Number and Date
2021000149 2021.05.12
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2021/000149 2013.11.28
(40) Publication Number and Date
SM /T/2021/000149 2021.05.12
(30) Priority Details
HU 2012P000691
2012.11.29
(51) IPC Classes
(72) Inventor
(IT) LASZLOVSZKY, István : Bartók Béla út 16., H-1111 Budapest, HU
(IT) DEBELLE, Marc : Emilio Noelting 16A, F-68100 Mulhouse, FR
(IT) NÉMETH, György József : Hüvösvölgyi út 151/A., H-1021 Budapest, HU
(IT) PITTER, János György : Alsóerdösor u. 55/A, H-2030 Érd, HU
(IT) SZATMÁRI, Balázs : Sarlósfecske u. 21., H-1173 Budapest , HU
(74) Representative Name
(IT) CAPASSO, Olga : Via Consiglio dei Sessanta, 99, 47891 Dogana RSM, SM
(54) Title
(IT) TRANS-4-{2-[4-(2,3-DICLOROFENIL)-PIPERAZIN-1-IL]-ETIL}-N,N-DIMETILCARBAMOIL-CICLOESILAMMINA PER IL TRATTAMENTO DEI SINTOMI NEGATIVI PRIMARI DELLA SCHIZOFRENIA
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2021.07.12
Event NameDateStatus
Filing2013.11.28Filed
Brevetto EPO concesso2021.05.12Published
Ricevuta pagamento annualita 92021.10.25Payed
Ricevuta pagamento annualita 102022.10.20Payed
Ricevuta pagamento annualita 112023.10.26Payed
Ricevuta pagamento annualita 122024.10.28Payed